MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.550
-0.030 (-1.90%)
Sep 6, 2024, 4:00 PM EDT - Market closed
MIRA Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 6.94 | 6.95 | 4.7 | 1.47 | 0.16 |
| Research & Development | 2.78 | 1.57 | 2.35 | 0.68 | 0.04 |
| Operating Expenses | 9.72 | 8.53 | 7.05 | 2.15 | 0.2 |
| Operating Income | -9.72 | -8.53 | -7.05 | -2.15 | -0.2 |
| Interest Expense | -3.16 | -3.46 | -0.01 | -0.02 | -0 |
| Pretax Income | -12.78 | -11.98 | -7.06 | -2.18 | -0.2 |
| Net Income | -12.78 | -11.98 | -7.06 | -2.18 | -0.2 |
| Net Income to Common | -12.78 | -11.98 | -7.06 | -2.18 | -0.2 |
| Shares Outstanding (Basic) | 19 | 19 | 18 | 13 | - |
| Shares Outstanding (Diluted) | 19 | 19 | 18 | 13 | - |
| Shares Change (YoY) | 9.13% | 5.69% | 38.60% | - | - |
| EPS (Basic) | -0.66 | -0.65 | -0.40 | -0.17 | - |
| EPS (Diluted) | -0.66 | -0.65 | -0.40 | -0.17 | - |
| Free Cash Flow | -4.71 | -4.53 | -5.6 | -1.38 | -0.2 |
| Free Cash Flow Per Share | -0.24 | -0.24 | -0.32 | -0.11 | - |
| EBIT | -9.72 | -8.53 | -7.05 | -2.15 | -0.2 |
| Advertising Expenses | - | 0.1 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.